The University of Chicago Medicine Comprehensive Cancer Center (UCCCC) and Eli Lilly and Company (Lilly) have partnered to help patients gain greater access to potential cancer treatments by participating in clinical trials. The two-year partnership creates a strong foundation for the two organizations to work together over time to expand access to clinical trials with innovative investigational therapies and improve the overall research experience.